| Literature DB >> 22112366 |
Jean Bernard Lekana-Douki1, Sandrine Lydie Oyegue Liabagui, Jean Bernard Bongui, Rafika Zatra, Jacques Lebibi, Fousseyni S Toure-Ndouo.
Abstract
BACKGROUND: Malaria remains a major public health problem, especially in tropical and subtropical regions because of the emergence and widespread of antimalarial drug resistance. Traditional medicine represents one potential source of new treatments. Here, we investigated the in vitro antiplasmodial activity of bark extracts from two Fabaceae species (Tetrapleura tertaptera and Copaifera religiosa) traditionally used to treat malaria symptoms in Haut-Ogooué province, Gabon.Entities:
Year: 2011 PMID: 22112366 PMCID: PMC3247923 DOI: 10.1186/1756-0500-4-506
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
In vitro antiplasmodial activity, cytotoxicity, and selectivity index of the plant extracts
| Plants species | Voucher number | Extract | Antiplasmodial activity | Cytotoxicity MRC-5 | Selectivity Indexc | ||
|---|---|---|---|---|---|---|---|
| FCB | 3D7 | (CC50 μg/ml)b | FCB | 3D7 | |||
| D. N. 584 | CH2Cl2 | 13.4 ± 3.6 | 8.5 ± 4.7 | 4.87 ± 0.5 | 0.37 | 0.61 | |
| CH3OH | 500.7 ± 16.4 | 480.9 ± 34.2 | NT | ND | ND | ||
| J.J. WIE 6388 | CH2Cl2 | 10.1 ± 3.2 | 13.0 ± 5.1 | 79.9 ± 24.3 | 7.91 | 6.15 | |
| CH3OH | 34.6 ± 4.7 | 29.6 ± 6.9 | 89.4 ± 10.8 | 2.58 | 3.02 | ||
| Chloroquine | 324.8 ± 16.8 nM | 7.9 ± 2.3 nM | |||||
a: IC50: (Inhibition concentration 50%) is the drug concentration that reduced parasitemia by 50%
b: CC50: (Cytotoxic concentration drug 50%) is the drug concentration that reduced the number of viable MRC-5 cells by 50%
c: Selectivity index = Ratio CC50/IC50
NT: Not Tested
ND: Not Determined
In vitro antiplasmodial activity (IC50) of Fabaceae extracts on field isolates of P. falciparum
| IC50 ± SD (μg/mL) | IC50 ± SD (nM) | |||||
|---|---|---|---|---|---|---|
| Isolates | DHA (nM) | CQ (nM) | ||||
| CH2Cl2 | MeOH | CH2Cl2 | MeOH | |||
| 0.6 ± 0.7 | 11.0 ± 0.6 | 1.1 ± 0.4 | 200 ± 10.6 | 0.3 ± 0.1 | 3.4 ± 2.0 | |
| 0.5 ± 0.2 | 12.6 ± 0.9 | 0.9 ± 0.5 | 75 ± 4.8 | 0.6 ± 0.2 | 110.0 ± 7.3 | |
| 0.8 ± 0.3 | 10.2 ± 2.3 | 1.6 ± 0.8 | 20 ± 3.5 | 4.8 ± 1.0 | 107.7 ± 2.1 | |
| 1.2 ± 0.5 | 14.7 ± 1.5 | 3.6 1.3 | 25.6 ± 2.1 | 5.8 ± 0.8 | 143.0 ± 2.3 | |
| 5.0 ± 1.1 | 75.4 ± 8.6 | 30.3 ± 1.3 | 400 ± 23.4 | 0.9 ± 0.2 | 100.0 ± 9.3 | |
| 0.9 ± 0.4 | 23.8 ± 9.4 | 9.1 ± 1.6 | 236 ± 9.7 | 2.0 ± 0.5 | 3.6 ± 0.8 | |
| 1.2 ± 0.2 | 13.5 ± 7.8 | 0.9 ± 0.3 | 88 ± 10.2 | 0.6 ± 0.3 | 212.8 ± 3.9 | |
| 1.0 ± 0.5 | 9.3 ± 0.9 | 2.4 ± 1.7 | 45.2 ± 1.8 | 5.9 ± 1.8 | 183.8 ± 12.8 | |
| 2.1 ± 0.5 | 11.2 ± 2.6 | 1.1 ± 0.3 | 320.7 ± 9.3 | 6.4 ± 1.1 | 278.5 ± 5.4 | |
| 0.7 ± 0.6 | 12.5 ± 3.4 | 0.9 ± 0.6 | 264.6 ± 8.4 | 11.1 ± 1.7 | 29.5 ± 10.4 | |
| 1.7 ± 0.4 | 13.8 ± 1.4 | 1.5 ± 0.2 | 321.3 ± 3.1 | 1.0 ± 0.4 | 70.6 ± 2.6 | |
| 2.6 ± 1.0 | 14.9 ± 0.7 | 2.7 ± 0.6 | 200.1 ± 6.0 | 1.9 ± 0.4 | 7.8 ± 2.1 | |
| 0.8 ± 0.3 | 11.7 ± 1.6 | 3.6 ± 1.5 | 697.6 ± 8.2 | 1.0 ± 0.3 | 375.2 ± 4.3 | |
| 0.7 ± 0.3 | 9.9 ± 0.8 | 1.3 ± 0.5 | 345.7 ± 13.6 | 0.1 ± 0.2 | 60.0 ± 2.3 | |
| 1.8 ± 1.4 | 14.2 ± 3.7 | 2.6 ± 0.6 | 294.3 ± 7.3 | 0.6 ± 0.2 | 17.9 ± 1.8 | |
| 0.7 ± 0.3 | 15.9 ± 0.9 | 0.8 ± 0.6 | 219.6 ± 20.3 | 2.1 ± 0.6 | 26.6 ± 2.1 | |
| 0.9 (0.5-5.0) | 13.1 (9.3-75.4) | 1.5 (0.8-30.8) | 227.8 (20.0-697.6) | 1.45 (0.1-11.1) | 85.3 (3.4-375.2) | |
Median (Min-Max)*: median of IC50 with minimum and maximum.
DHA: dihydroartemisinin.
CQ: chloroquine.